Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Submitted by
admin
on July 25, 2012 - 9:33am
Source:
Yahoo/Fly on the Wall
News Tags:
EntreMed
triple-negative breast cancer
breast cancer
ENMD-2076
Headline:
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Do Not Allow Advertisers to Use My Personal information
